Targeting the ATP Synthase in <i>Staphylococcus aureus</i> Small Colony Variants, <i>Streptococcus pyogenes</i> and Pathogenic Fungi
The ATP synthase has been validated as a druggable target with the approval of the ATP synthase inhibitor, bedaquiline, for treatment of drug-resistant <i>Mycobacterium tuberculosis</i>, a bacterial species in which the ATP synthase is essential for viability. Gene inactivation studies have also sho...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2021-04-01
|
| Col·lecció: | Antibiotics |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/2079-6382/10/4/376 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|